Everand Logo

Welcome to Everand!

  • Discover this podcast and so much more

    Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

    Itacitinib monotherapy for GVHD, the role of ERG in EVI1-driven AML, and germline DDX41 mutations in myeloid neoplasms

    Itacitinib monotherapy for GVHD, the role of ERG in EVI1-driven AML, and germline DDX41 mutations in myeloid neoplasms

    FromBlood Podcast

    Start listeningView podcast show

    Itacitinib monotherapy for GVHD, the role of ERG in EVI1-driven AML, and germline DDX41 mutations in myeloid neoplasms

    FromBlood Podcast

    ratings:
    Length:
    22 minutes
    Released:
    Feb 2, 2023
    Format:
    Podcast episode

    Description

    In this week's episode, we’ll discuss the safety and efficacy of itacitinib monotherapy in low-risk acute GVHD, learn how ERG was discovered to be a key transcriptional target in EVI1-driven AML, and define a unique subtype of myeloid neoplasms characterized by germline DDX41 mutations.
    Released:
    Feb 2, 2023
    Format:
    Podcast episode

    Titles in the series (100)

    The Blood Podcast summarizes content recently published in Blood the most cited peer-reviewed publication in the field of hematology.